|
|
Volumn 9, Issue 5, 2007, Pages 339-341
|
|
Cardiovascular risk in clinical decision making
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRAVASTATIN;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
CLINICAL DECISION MAKING;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COGNITION;
CORONARY ARTERY DISEASE;
COST EFFECTIVENESS ANALYSIS;
DISABILITY;
EDUCATION;
HEALTH CARE POLICY;
HEART FAILURE;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
HYPERTENSION;
INCIDENCE;
ISCHEMIC HEART DISEASE;
MORBIDITY;
NOTE;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
SECONDARY PREVENTION;
SENSITIVITY AND SPECIFICITY;
SPAIN;
STROKE;
UNSTABLE ANGINA PECTORIS;
CARDIOVASCULAR DISEASES;
DECISION MAKING;
EVIDENCE-BASED MEDICINE;
HEALTH POLICY;
HUMANS;
RISK FACTORS;
RISK REDUCTION BEHAVIOR;
|
|
EID: 36849000721
PISSN: 15226417
EISSN: None
Source Type: Journal
DOI: 10.1007/s11906-007-0061-z Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
